These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10076394)

  • 1. Screening for ovarian cancer: is it worth the risk?
    Bell R
    Nurs Times; 1999 Jan 20-26; 95(3):52-3. PubMed ID: 10076394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACR appropriateness criteria© ovarian cancer screening.
    Brown DL; Andreotti RF; Lee SI; Dejesus Allison SO; Bennett GL; Dubinsky T; Glanc P; Horrow MM; Lev-Toaff AS; Horowitz NS; Podrasky AE; Scoutt LM; Zelop CM
    Ultrasound Q; 2010 Dec; 26(4):219-23. PubMed ID: 21084936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women.
    Skates SJ; Menon U; MacDonald N; Rosenthal AN; Oram DH; Knapp RC; Jacobs IJ
    J Clin Oncol; 2003 May; 21(10 Suppl):206s-210s. PubMed ID: 12743136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Screening for ovarian cancers: critical analysis].
    Pennehouat G; Gugliemina JN; Naouri M; Créquat J; Bouret JM; Thébault Y; Madelenat P
    Contracept Fertil Sex; 1993 Mar; 21(3):223-30. PubMed ID: 7951617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress report on ovarian cancer screening. Scientists are making headway in detecting ovarian cancer at an earlier stage.
    Harv Womens Health Watch; 2010 Apr; 17(8):1-3. PubMed ID: 20506601
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening and detection of ovarian cancer.
    Breedlove G; Busenhart C
    J Midwifery Womens Health; 2005; 50(1):51-4. PubMed ID: 15637515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
    Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian cancer screening. American College of Radiology. ACR Appropriateness Criteria.
    Böhm-Vélez M; Mendelson E; Bree R; Finberg H; Fishman EK; Hricak H; Laing F; Sartoris D; Thurmond A; Goldstein S
    Radiology; 2000 Jun; 215 Suppl():861-71. PubMed ID: 11037511
    [No Abstract]   [Full Text] [Related]  

  • 9. How appropriate are the american college of radiology appropriateness criteria for ovarian cancer screening.
    Dubinsky TJ
    Ultrasound Q; 2010 Dec; 26(4):225-6. PubMed ID: 21084937
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mass-screening for ovarian cancer].
    Sato S; Higuchi T; Yokoyama Y; Sakamoto T
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():601-4. PubMed ID: 15535316
    [No Abstract]   [Full Text] [Related]  

  • 11. Ovarian cancer screening: a primary care guide.
    Thompson SD
    Lippincotts Prim Care Pract; 1998; 2(3):244-50. PubMed ID: 9644439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Screening for ovarian cancer].
    Bjørge T; Dørum A; Tropé CG
    Tidsskr Nor Laegeforen; 2000 May; 120(12):1444-8. PubMed ID: 10851943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CA-125: a biomarker put to the test.
    Schmidt C
    J Natl Cancer Inst; 2011 Sep; 103(17):1290-1. PubMed ID: 21852262
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term follow-up of the Stockholm screening study on ovarian cancer.
    Einhorn N; Bast R; Knapp R; Nilsson B; Zurawski V; Sjövall K
    Gynecol Oncol; 2000 Dec; 79(3):466-70. PubMed ID: 11104621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating tumour markers in ovarian tumours.
    von Schlippe M; Rustin GJ
    Forum (Genova); 2000; 10(4):383-92. PubMed ID: 11535987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Worry about ovarian cancer risk and use of ovarian cancer screening by women at risk for ovarian cancer.
    Andersen MR; Peacock S; Nelson J; Wilson S; McIntosh M; Drescher C; Urban N
    Gynecol Oncol; 2002 Apr; 85(1):3-8. PubMed ID: 11925113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Listen for the "whispering disease". Learn the subtle signs and symptoms of ovarian cancer.
    Martin VR
    Nurs Manage; 2000 Apr; 31(4):30-1. PubMed ID: 15127636
    [No Abstract]   [Full Text] [Related]  

  • 18. Ovarian cancer tumor marker behavior in asymptomatic healthy women: implications for screening.
    Crump C; McIntosh MW; Urban N; Anderson G; Karlan BY
    Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1107-11. PubMed ID: 11045795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for ovarian cancer: a systematic review.
    Bell R; Petticrew M; Luengo S; Sheldon TA
    Health Technol Assess; 1998; 2(2):i-iv, 1-84. PubMed ID: 9561894
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening for ovarian cancer: a pilot randomised controlled trial.
    Jacobs IJ; Skates SJ; MacDonald N; Menon U; Rosenthal AN; Davies AP; Woolas R; Jeyarajah AR; Sibley K; Lowe DG; Oram DH
    Lancet; 1999 Apr; 353(9160):1207-10. PubMed ID: 10217079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.